key: cord-0933008-r7fcix35 authors: Aggarwal, Gaurav; Lippi, Giuseppe; Lavie, Carl J.; Henry, Brandon Michael; Sanchis‐Gomar, Fabian title: Diabetes Mellitus Association with Coronavirus Disease 2019 (COVID‐19) Severity and Mortality: A Pooled Analysis date: 2020-07-16 journal: J Diabetes DOI: 10.1111/1753-0407.13091 sha: d906231cff2968f7bae6a2f227ef729c296d5eba doc_id: 933008 cord_uid: r7fcix35 nan survivors and non-surviving COVID-19 patients, 96 (15.5%) of them previously diagnosed with DM. Details of the included studies are listed in Table 1 . The results of the pooled analysis are presented in Figure 1 . COVID-19 patients previously diagnosed with DM were found to be associated with a statistically significant increased risk of worse COVID-19 infection (OR: 2.60 [95% CI: 1.96 to 3.45], I 2 =56%, Cochran's Q=24.9, p=0.01). In the pooled analysis of the four studies reporting mortality data, significant association was found with increased risk of mortality in COVID- 19 Meta-regression analysis showed no effect of age (Supplementary figure 1) or gender The results of our pooled analysis demonstrate that the presence of DM may significantly worsen the clinical course of COVID-19. Overall, we found a ~2-fold increased odds of severe COVID-19 and a ~2-fold increased odds of mortality in DM patients with this infection compared to non-DM. There are several possible mechanisms explaining these findings. Patients with DM have been inherently known to have higher cumulative mortality, mostly owing to cardiovascular and renal disease. 19 DM has also been previously associated with worse outcomes in patients with severe This article is protected by copyright. All rights reserved. Manuscript submitted to Journal of Diabetes acute respiratory syndrome (SARS) infection. 20 The circulating levels of some cytokines such as interleukin-6 (IL-6) were found to be higher in COVID-19 patients with DM, which suggests the presence of an underlying pro-inflammatory milieu as one mechanism linking DM to worse severity outcomes in COVID-19 patients. 21 It is also noteworthy that DM patients are more frequently overweight or have a higher prevalence of obesity, which could also contribute to worsen the prognosis of restrictive lung diseases. A limitation of our analysis is in the fact that we could not use exclusion criteria to obtain data from the largest possible number of studies. We did perform sensitivity analysis and analysis for publication bias to assess for heterogeneity. To assess the effect of age and gender as confounding variables in our analysis, we also performed a meta-regression which showed no impact on association of DM with disease severity or mortality in COVID-19 patients. Since the included studies were observational, we cannot rule out possibility of confounding and reverse causation. We did not have data on use of anti-hyperglycemic agents, duration of diabetes and associated diabetic micro-and macro-vascular complications. Due to the limited number of studies and small sample size, large prospective studies would be advisable to confirm our findings, data regarding COVID-19 are still in nascent stage and our findings may help clinicians and policymakers implement risk stratification models and put the limited healthcare resources to judicious use. This article is protected by copyright. All rights reserved. There a ~2-fold increased odds of severe COVID-19 and a ~2-fold increased risk of odds of mortality in patients with history of diabetes mellitus compared to those without diabetes mellitus. Patients with a history of diabetes mellitus should be closely monitored if they get infected with COVID-19. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study Clinical Characteristics of Coronavirus Disease 2019 in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med Clinical features and treatment of COVID-19 patients in northeast Chongqing Clinical Characteristics of 138 Hospitalized Patients With Novel Coronavirus-Infected Pneumonia in Wuhan Clinical Features of 69 Cases with Coronavirus Disease Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease Analysis of clinical characteristics of 49 patients with new type of coronavirus pneumonia in Jiangxi region Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Analysis of Myocardial Injury and Cardiovascular Diseases in Critical Patients with New Coronavirus Pneumonia The American Diabetes Association and World Health Organization Classifications for Diabetes. Their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area COVID-19: consider cytokine storm syndromes and immunosuppression